Dimensional Fund Advisors
NNVC icon

Dimensional Fund Advisors’s NanoViricides NNVC Stock Holding History

Dimensional Fund Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,915
Closed -$17.9K – 3356
2024
Q3 		$17.9K Buy
+11,915
New +$22.1K ﹤0.01% 3338
2022
Q1 		– Sell
-29,154
Closed -$108K – 3544
2021
Q4 		$108K Buy
29,154
+3,168
+12% +$14.4K ﹤0.01% 3430
2021
Q3 		$121K Buy
+25,986
New +$108K ﹤0.01% 3406

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Dimensional Fund Advisors's NNVC Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of NanoViricides (NNVC) in Q4 2024, closing a stake of 11,915 shares — an estimated $17.9K sold.

Dimensional Fund Advisors first reported a position in NNVC in Q3 2021 and held it in 3 quarters. The position peaked at $121K in Q3 2021. 36 funds tracked by Wall St. Rank hold NNVC as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining NanoViricides position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 11,915 NanoViricides shares in Q4 2024, an estimated $17.9K.
  • Dimensional Fund Advisors first reported a position in NanoViricides in Q3 2021 and held it in 3 quarters.
  • Dimensional Fund Advisors's NanoViricides position peaked at $121K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held NanoViricides as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.